169 related articles for article (PubMed ID: 17241287)
1. Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study.
Marin C; Aguilar E; Mengod G; Cortés R; Obeso JA
Eur J Neurosci; 2007 Jan; 25(1):259-69. PubMed ID: 17241287
[TBL] [Abstract][Full Text] [Related]
2. Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats.
Marin C; Aguilar E; Mengod G; Cortés R; Obeso JA
Eur J Neurosci; 2009 Sep; 30(5):823-32. PubMed ID: 19712101
[TBL] [Abstract][Full Text] [Related]
3. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
[TBL] [Abstract][Full Text] [Related]
4. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
Cenci MA; Lee CS; Björklund A
Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.
Song L; Kong M; Ma Y; Ba M; Liu Z
Brain Res; 2009 Jun; 1276():171-9. PubMed ID: 19393228
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats.
Oh JD; Chartisathian K; Ahmed SM; Chase TN
J Neurosci Res; 2003 Jun; 72(6):768-80. PubMed ID: 12774317
[TBL] [Abstract][Full Text] [Related]
7. Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes.
Marin C; Aguilar E; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
Neurobiol Dis; 2008 Dec; 32(3):340-8. PubMed ID: 18722529
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Glavan G; Zivin M
Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
[TBL] [Abstract][Full Text] [Related]
9. Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.
Bové J; Serrats J; Mengod G; Cortés R; Aguilar E; Marin C
Synapse; 2006 Jun; 59(7):435-44. PubMed ID: 16498608
[TBL] [Abstract][Full Text] [Related]
10. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
12. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
Périer C; Marin C; Jimenez A; Bonastre M; Tolosa E; Hirsch EC
J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
[TBL] [Abstract][Full Text] [Related]
13. Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.
Glavan G
Brain Res; 2008 Oct; 1236():216-24. PubMed ID: 18721798
[TBL] [Abstract][Full Text] [Related]
14. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
Lindgren HS; Rylander D; Ohlin KE; Lundblad M; Cenci MA
Behav Brain Res; 2007 Feb; 177(1):150-9. PubMed ID: 17157933
[TBL] [Abstract][Full Text] [Related]
15. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression.
Duty S; Brotchie JM
Exp Neurol; 1997 Apr; 144(2):423-32. PubMed ID: 9168843
[TBL] [Abstract][Full Text] [Related]
17. Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats.
Tani Y; Ogata A; Koyama M; Inoue T
Eur J Pharmacol; 2010 Dec; 649(1-3):218-23. PubMed ID: 20858480
[TBL] [Abstract][Full Text] [Related]
18. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
Blandini F; Levandis G; Bazzini E; Nappi G; Armentero MT
Eur J Neurosci; 2007 Jan; 25(2):397-405. PubMed ID: 17284180
[TBL] [Abstract][Full Text] [Related]
19. LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.
Marin C; Jiménez A; Bonastre M; Vila M; Agid Y; Hirsch EC; Tolosa E
Synapse; 2001 Oct; 42(1):40-7. PubMed ID: 11668589
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
